Product Banner

Anti-Infective Pharmaceuticals Market in India 2012

Anti-Infective Pharmaceuticals Market in India 2012

* Required Fields

Regular Price: $1,995.00

Special Price $997.50

Regular Price: $1,995.00

Special Price $997.50

  • Apr 06, 2012
  • 82 pages
  • Netscribes
Abstract
Anti-infective pharmaceuticals market in India is the largest contributor to domestic pharmaceutical sales, contributing around 18%. Since India has a huge patient pool, the Indian market is characterized by a huge demand for anti-infective drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the patient population, increasing number of vaccine approvals, increase in health insurances and introduction of newer and better drugs is helping the market to grow. The Indian Government, on its part, has introduced some control programmes, undertaken various Private Partnership Projects (PPP) and has taken initiatives to reduce drug prices. The market is expected to exhibit steady growth over the next few years.

The report begins with the introduction section which offers a brief classification of the anti infectives market. It then moves to the market overview section which provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth.

An analysis of the drivers explains the factors for growth of the industry including increasing patient population, increasing vaccine approvals, increase in health insurances and introduction of newer and better drugs. The key challenges include pricing pressure and logistic problems in the vaccine market.

The government initiatives section gives a brief description of the different control programmes undertaken by the Government. It also analyses the efforts to reduce drug prices, changes in the customs duty structure and the various PPP projects undertaken by the Government.

A brief overview of the drug regulations and patents is presented in the next section. It focuses the different stages of clinical trial that a drug must pass through. Drug regulations in India and drugs approved for marketing have been provided. The section also provides a list of important patent approvals for anti infective drugs.

The competition section gives overview of pharmaceutical companies in the country operating in the anti diabetic pharmaceutical and insulin segments. Thereafter, the report highlights the features of the major players operating in the market in detail. It includes elaborate profile of the major players in the market along with their financial analysis. Porters Five Forces Analysis has been incorporated for a brief but effective understanding of the market scenario. It also incorporates the recent developments in the Anti Infective Pharmaceutical industry.

The strategic recommendations section focuses on some effective strategic decisions which can be taken up by companies to increase their market shares. Foray into the production of adult vaccines and improvement in the logistics of the vaccine market will help the companies increase their customer base. Also, efficient marketing strategies, like strategic alliances of foreign companies with local manufacturers, or tie-ups of domestic manufacturers with Government bodies and non-governmental organizations will increase the profitability of the companies.
Table of Contents
Page 1: Executive summary

Introduction
Page 2: Classification of anti infective pharmaceutical market
Page 3: Types of anti infective drugs

Market Overview
Page 4: Global Anti-Infective Pharmaceuticals Market - Overview, Size & Growth (Value: 2010-15e),
Page 5: Indian Anti-Infective Pharmaceuticals Market- Overview, Size & Growth (Value: 2010-2015e), Growth in Therapeutic segments

Drivers & Challenges
Page 6: Summary
Page 7-10: Drivers
Page 11: Challenges

Government initiatives
Page 12: Summary
Page 13-20: Government Initiatives

Market value chain, regulation and patents
Page 21: Pharmaceutical value chain
Page 22: Phases of clinical trials
Page 23-24: Drug regulations
Page 25: Regulatory framework
Page 26-28: List of patent approvals

Competition
Page 29: Market Competition - Porter's Five Forces Analysis
Page 30- 71: Major Public Companies
Abbott India Limited
Cipla Limited
Claris Lifesciences Limited
GlaxoSmithKline Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited
Lupin Limited
Novartis India Limited
Panacea Biotec Limited
Pfizer Limited
Ranbaxy Laboratories Limited
Sun Pharmaceutical Industries Limited
Torrent Pharmaceuticals Limited
Wockhardt Limited
Gilead Sciences Inc.
Page 72- 80: Major Private Companies
Bristol-Myers Squibb India Private Limited
Takeda Pharmaceuticals India Private Limited
Watson Pharma Private Limited
Page 81: Recent Developments

Strategic Recommendation
Page 82: Strategic Recommendations
List of Figures
Market Overview
1. Anti Infective Pharmaceutical Market- Global Market Size and Growth (Value wise 2010 - 2015e)
2. Anti Infective Pharmaceutical Market - India Market Size and Growth (Value-Wise, 2010 - 2015e)
3. Top pharmaceutical segments (Percentage wise 2010)

Competition
4. Financial Snapshot
5. Key Business segments (only Public Players)
6. Key Geographic segments (only Public Players)
Except GlaxoSmithKline Pharmaceuticals Limited


List of Tables

Market Overview
1. Top selling vaccines - global market
Government Initiatives
2. Cost comparison of drugs in JAS stores and outside
Market Value Chain, Regulation and Patent
3. Tabular representation of drugs approved in recent past (2009- 2011)
4. Tabular representation of regulatory framework of Indian Pharmaceutical Industry
5. Tabular representation of USFDA patent approvals
Competition
4. Company profiles (All companies)
a. Company information
b. Products and services
c. Key people
d. Key Financial Performance Indicators
e. Key Ratios
Except for Pfizer Limited
f. Business Highlights
Appendix
5. Ratio Calculations
List of Tables
Companies Covered
1. Abbott India Limited
2. Cipla Limited
3. Claris Lifesciences Limited
4. GlaxoSmithKline Pharmaceuticals Limited
5. Glenmark Pharmaceuticals Limited
6. Lupin Limited
7. Novartis India Limited
8. Panacea Biotec Limited
9. Pfizer Limited
10. Ranbaxy Laboratories Limited
11. Sun Pharmaceutical Industries Limited
12. Torrent Pharmaceuticals Limited
13. Wockhardt Limited
14. Gilead Sciences Inc.
15. Bristol-Myers Squibb India Private Limited
16. Takeda Pharmaceuticals India Private Limited
17. Watson Pharma Private Limited